Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Research and Markets: Next Generation Sequencing (NGS) Report 2013: How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

10/10/2013 | 10:30am US/Eastern

Research and Markets (http://www.researchandmarkets.com/research/ddm37b/next_generation) has announced the addition of the "Next Generation Sequencing Report 2013" report to their offering.

The Next Generation Sequencing market is poised to reach $4.4B in 2018!

How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

NGS technologies drive the way toward personalized medicine

Our analysis provides 2013-2018 market data, along with player market shares at both equipment and consumable levels. Moreover, positioning strategy of each supplier has been analyzed in the document.

Discover the NGS market's complex organization, splitted in four segments

The market segmentation is a tool used to provide a vision of the market. Based on technical and economic criteria, fours segments have been identified: research, forensics, diagnostics and consumer.

Until recently, uses of Next Generation Sequencing tools were limited to research (human whole genome, exome, small genome, targeted, transcriptome, RNA profiling, chIP-Seq, metagenomics).

Nowadays, NGS technologies have found applications mainly in two fields: clinical diagnostics and forensics.

Our investigation describes both current and future applications.

Next Generation Sequencing technologies overview

  • In April 2003, human genome project was declared complete. This first human genome sequencing took 13 years, mobilized 20000 researchers and cost $3B!
  • Since the early 2000s, sequencing technologies have come a long way from Sanger sequencing (also called 1st generation sequencing) used for the human genome project to the Next Generation Sequencing technologies available today.
  • By sequencing a large number of DNA molecules in parallel after PCR amplification, technology developers have been able to sharply increase machine throughput by a factor of 10, along with a steep price reduction.
  • The launch of a new detection method based on electrochemical detections was also a huge step forward for the sequencing world.
  • Today, based on these new technologies, we can sequence the whole human genome in less than three hours with one laboratory technician and a total cost around $1000.
  • Technologies under development are poised to extend the boundaries with a targeted sequencing cost of $100.
  • All technologies currently in use and those under development are presented in our report. Benchmarking is also presented for eight different sequencing applications.

New opportunities arise for cartridge makers

  • The wide adoption of NGS technology has changed the way NGS suppliers are generating revenue. A shift occurred in the sales mix, moving from instruments to consumables which have a higher gross margin than instruments.
  • This leads to an increase in revenue based on consumable sales.
  • The number of NGS Platforms used worldwide will exploded in the next several years and the run time will continue to decrease. Therefore, the market of NGS consumables will follow.

Report's key features

- 2013-2018 Next Generation Sequencing equipment market

- 2013-2018 Next Generation Sequencing consumable market

- Market segmentation which highlights current and future applications

- Overview of sequencing technologies and cartridges associated

- Detailed supply chain and business model analysis highlighting the major changes expected over next few years

- Company profiles of the main players

Report objectives

- Provide an overview of global NGS market both at equipment and consumable levels.

- Present main players and technologies involved

- Analyze both technical and market trends

- Focus on microfluidic consumable cartridges used for genome testing

- Supply Chain analysis

Key Topics Covered:

1. Executive summary

2. Introduction

3. Market data

4. Market segmentation

5. Next Generation Sequencing technologies overview

6. Value chain and supply chain

7. Market trends and challenges

8. Company profiles

Companies Mentioned

- 23andme

- Affymetrix

- Azco Biotech Inc

- Baseclear

- Base 4

- BGI-Shenzhen

- Completegenomics

- DNAvision

- Genia Technologies

- Genapsys

- GnuBIO

- Hitachi

- Illumina

- LaserGen

- NabSys

- Noblegen Biosciences

- Oxford Nanopore Technologies

- Pacific Biosciences

- Qiagen

- Roche 454

- Stratos Genomics Inc.

- Thermo Fisher Scientific

- TSMC

For more information visit http://www.researchandmarkets.com/research/ddm37b/next_generation

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


© Business Wire 2013
React to this article
Latest news
Date Title
07:44a PEUGEOT : Appeal after bike stolen
07:44a MICROSOFT : Gates tops Forbes billionaires list
07:44a NORWEGIAN ENERGY ASA : Minutes from extraordinary general meeting
07:44a SONUS NETWORKS : brings intelligence and security to real time communications with the introduction of new architectural platform
07:44a BURSA DE VALORI BUCURESTI : BRIEF: New companies interested in BVB's AeRO market to introduce themselves to investors, today
07:44a RESEARCH AND MARKETS : 2015 Strategic Analysis of Toyota Motor Global Product Portfolio
07:43a J SAINSBURY : New hope for jobs boost at depot site ; Sainsbury's confirms talks with potential developers <'Strong interest' in giant development near airport
07:43a MICROSOFT : Tariceanu, about speculations of involvement in Microsoft case: If such elements exist, send them to DNA
07:43aDJSpringleaf Agrees to $4.25 Billion Deal for Citigroup's OneMain -- 5th Update
07:42a J SAINSBURY : Let's hope no further delay for depot site ; OPINION
Latest news
Advertisement
Hot News 
ISG : Shares Hit As It Swings To Loss, Launches Discounted Placing (ALLISS)
GLOBAL BIOENERGIES : reports first isobutene production from waste biomass
GOLDEN SAINT RESOURCES : Surges On Darwin Loan Plan, Upcoming Diamond Sales
FILTRONIC : CFO Replaces CEO As Full Year Revenue Outlook Worsens
MCCOLL RETAIL : Posts Higher Annual Profit But First-Quarter Of New Year Weak
Most Read News
03/02 OPOWER : reports 4Q loss
03:06a GLENCORE : 2014 profit in line, takes $1.1 bln charge on commodity prices
03:01a WARP 9 : Specialty Art Seller Selects Warp 9 for Magento E-Commerce Development
03/02 ROYAL DUTCH SHELL A : Energy debate shapes economy, environment
04:52a Barclays takes 750 million-pound charge as FX settlement looms
Most recommended articles
07:43aDJSpringleaf Agrees to $4.25 Billion Deal for Citigroup's OneMain -- 5th Update
07:38aDJAUTOZONE : Earnings Rise on Increased Inventory
07:37a Scotiabank profit constrained by 'softer' investment banking
07:34a TSX set to open higher as Brent rebounds
07:34aDJSharp President To Present Turnaround Plan to MUFG, Mizuho -- Update
Dynamic quotes  
ON
| OFF